Subscribe
bangoland / Shutterstock.com
4 September 2025NewsAmericasMarisa Woutersen

Roche resolves cancer test dispute with Stanford affiliated startup

The deal brings to a close a clash over DNA sequencing technology for cancer detection, with both sides agreeing to dismiss their claims.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Roche sues over blockbuster cancer drug as key patent protection expires
19 August 2025   In a New Jersey lawsuit, Henlius and Organon are accused of submitting an aBLA for a biosimilar that infringes two dozen patents.
Americas
Tempus sues competitor over AI cancer diagnostic tech
18 March 2025   Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.
Biotechnology
Roche loses appeal to block market entry of rival cancer drug
7 July 2020   A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled.


Editor's picks

Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025

Editor's picks

Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
UPC sees rising small molecule litigation with Pfizer in the hot seat
29 August 2025
Europe
Astellas win strengthens blockbuster drug's European position
20 August 2025
Europe
Four firms reach highest tier in WIPR’s 2025 Global Trade Secrets Rankings
18 August 2025
Americas
Latham steps into dispute over $6bn treatment, replacing Kirkland
13 August 2025
Americas
BMS blocks biosimilar version of blockbuster cancer drug in India
21 July 2025

More on this story

Americas
Roche sues over blockbuster cancer drug as key patent protection expires
19 August 2025   In a New Jersey lawsuit, Henlius and Organon are accused of submitting an aBLA for a biosimilar that infringes two dozen patents.
Americas
Tempus sues competitor over AI cancer diagnostic tech
18 March 2025   Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.
Biotechnology
Roche loses appeal to block market entry of rival cancer drug
7 July 2020   A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled.

More on this story

Americas
Roche sues over blockbuster cancer drug as key patent protection expires
19 August 2025   In a New Jersey lawsuit, Henlius and Organon are accused of submitting an aBLA for a biosimilar that infringes two dozen patents.
Americas
Tempus sues competitor over AI cancer diagnostic tech
18 March 2025   Complaint centres on AI-powered tools for cancer diagnostics | Tempus says its rival has a history of deliberately copying competitors’ technologies.
Biotechnology
Roche loses appeal to block market entry of rival cancer drug
7 July 2020   A Roche subsidiary will be unable to block Amgen from producing the cancer drug Mvasi (bevacizumab), the Court of Appeals for the Federal Circuit has ruled.

More features

The flaw that landed Sanofi a win in the rare disease space
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
UK firm expands in Germany with more litigation hires
Sandoz blocked by UK court from seeking Xarelto profits
An update on patenting in Ukraine, Russia and Eurasia
The rise of pro-NPE and patent sentiment in the US
UPC sees rising small molecule litigation with Pfizer in the hot seat
Why the Caribbean cannabis economy is ripe for IP protection